Articles tagged with Vaccine Research
A review of COVID-19 and other adult vaccination efforts found that cash transfers and lottery programs had limited outcomes in increasing vaccination rates, with some studies showing a slight over 2% increase in coverage. Non-cash incentives also showed no significant impact on vaccination uptake.
A recent study published in JAMA Network Open found that human papillomavirus (HPV) vaccination effectiveness differs significantly depending on the age at which it is administered. The researchers analyzed self-reported data from female participants and discovered that HPV vaccination is most effective when administered earlier in life.
The COVID-19 pandemic led to a marked decrease in routine childhood immunization rates in India, with significant implications for the country's immunization program and COVID-19 recovery policies. The study highlights the urgent need for catch-up vaccination campaigns and investments in health systems.
A survey of six European countries found strong public support for transferring COVID-19 vaccines to poorer nations and prioritizing those with the greatest need. Europeans consistently prioritized individuals most vulnerable, employed individuals, or those who lost income during the pandemic over unemployed individuals.
Researchers found that reduced NA activity enables HA mutations to become more neutral, and that this process is crucial for predicting future flu strains. The study aims to improve flu vaccine accuracy by understanding the interactions between HA and NA genes.
Researchers have reverse-engineered a virus linked to chronic kidney disease in cats and described its mechanism of infection. The feline morbillivirus, or FeMV, can spread from host to host through urine, similar to the zoonotic Nipah virus.
A new Danish-led study has demonstrated a way to strengthen the body's own ability to fight HIV, even when standard treatment is paused. The study found that monoclonal antibodies and Romidepsin can help the immune system recognize and kill infected cells.
Researchers analyzed 408 patients receiving immune checkpoint inhibitor therapy and found no increased risk of side effects from receiving both immunotherapy and the vaccine. The study supports NCCN's recommendations for COVID-19 vaccination in people with cancer, citing strong protection against severe COVID-19 for all variants.
Researchers created theoretical models to explain geographical clustering of vaccine hesitancy, attributing it to both social selection and social influence. The models found that these two processes independently generate clusters of high hesitancy, with social selection playing a key role when societies trust propaganda.
The Independent Task Force Report emphasizes the need for a One Health approach to prevent or respond adequately to the next pandemic. Key findings highlight the importance of 'Smart Surveillance' to identify high-threat pathogens and invest in R&D for innovative diagnostics, antiviral strategies, and therapeutic research.
New research highlights the need for comprehensive approaches to address COVID-19 vaccine hesitancy in UK South Asian communities, citing factors such as trust in authorities and media. The study's findings emphasize the complexity of the issue, beyond simplistic 'pro' or 'anti' Vaccine views.
A Johns Hopkins Medicine study found that COVID-19 booster shots are essential for maintaining long-term immunity against infection, particularly among older adults. The results support the CDC vaccination guidelines recommending COVID-19 boosters and highlight the importance of continued research on factors affecting immunity.
Researchers developed a highly effective and safe Zika vaccine technology that prevents systemic infection in pregnant mice and stimulates an immunogenic reaction. The vaccine was tested in various mouse models, proving safe and protective against the virus.
A recent study finds that exposure to proteins in common foods, vaccines, bacteria, and viruses can prime the immune system to attack SARS-CoV-2, potentially providing protection against COVID-19. The study's findings suggest that individuals with a history of exposure to these agents may be less susceptible to severe illness.
Researchers inculcated an avirulent Fusarium strain into Cavendish bananas, enhancing their resistance to Panama disease. This innovative approach may provide a sustainable solution for combating the devastating impact of Tropical Race 4 on global banana crops.
Researchers found that HPV vaccination rates rose significantly during the pandemic, particularly among younger children and adolescents. The study suggests that the increased vaccination rates may be attributed to changes in healthcare access and scheduling.
A recent study found that COVID-19 vaccination rates in NYC schools differed significantly by race and ethnicity, with majority Asian students having the highest rate at 66.2%. Vaccination rates also varied by borough, with Manhattan having the highest rate and Staten Island the lowest. The study suggests that understanding these diffe...
A recent study analyzing COVID-19 vaccination rates in New York City schools reveals significant disparities based on race and ethnicity. The research also highlights geographical variations in vaccination rates across the city.
Researchers at La Jolla Institute for Immunology discovered how Zika virus forces dendritic cells to churn out lipid molecules, allowing the virus to build copies of itself. This study provides a major step forward in developing antiviral therapies against multiple flavivirus infections.
A new study has suggested that recommended VACV-based vaccines will mount a robust immune response against the 2022 monkeypox virus. The research found that the genetic mutations observed in MPXV-2022 may not significantly affect vaccine-induced immunity.
A clinical trial evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine has begun enrolling adult volunteers. The trial aims to expand the vaccine supply and provide important information on immunogenicity, safety, and tolerability of alternative dosing approaches.
Researchers found that RK-33 inhibits the ability of SARS-CoV-2 to replicate in host cells, making it a potential broad-spectrum antiviral agent. The study showed that RK-33's antiviral capability remains consistent across four SARS-CoV-2 variants.
Researchers have identified two effective antibodies that neutralize all known strains of COVID-19, including Delta and Omicron variants. These breakthrough antibodies could eliminate the need for repeated booster vaccinations and strengthen immune systems, especially in at-risk populations.
A third vaccine dose offers better protection against Omicron infection and hospitalization compared to two doses. The study found that a third dose maintained longer protection against infection for a longer time.
The study found that a booster shot's effectiveness is the primary factor influencing people's willingness to receive it. Those who believe in vaccine efficacy are more likely to accept the booster shot, especially if it is made by Moderna or Pfizer. A partisan divide persists, with Democrats more willing and Republicans less willing.
A population-based retrospective cohort study found that COVID-19 vaccination during pregnancy is not associated with an increased risk of preterm birth, small for gestational age at birth, or stillbirth. The study concluded that COVID-19 vaccination during pregnancy can inform evidence-based decision-making about its safety.
A PSU study reveals that Republican voters and Black people are among the most hesitant to get vaccinated against COVID-19. The research suggests a regional approach may be more effective than a universal one in boosting vaccination rates.
Research reveals that smaller artificial cells lead to greater separation of molecules, allowing for a new approach to manipulate material properties. This discovery has potential applications in pharmaceuticals and cosmetics industries.
Researchers found no excess mortality in Massachusetts from February to June 2022, despite rising COVID-19 cases and hospitalizations. This suggests high levels of immunity benefiting those at highest risk from SARS-CoV-2 infection.
Researchers compared HPV prevalence among women born in the 1980s, 1990s, and before/after vaccination periods. The study found significant differences in HPV prevalence between these groups.
Advanced cervical cancer rates have been rising in the US, with a significant increase among White women and higher prevalence among Black women, particularly those in their mid-to-late 50s. The study found that obesity and older age at first birth may contribute to the rise in this type of cervical cancer.
Researchers estimated long-term effectiveness of Pfizer-BioNTech COVID-19 vaccine against SARS-CoV-2 infection and critical infections among 3.2 million South Korean adolescents. The study found high vaccine effectiveness in preventing severe illnesses.
A large Canadian study found no association between Covid-19 vaccination during pregnancy and increased risks of preterm birth or stillbirth. The study analyzed data from over 85,000 births and concluded that vaccination is effective against Covid-19 in pregnant individuals and their newborns.
Researchers discovered that presenting COVID-19 vaccine side effects in the context of other risks, such as motor vehicle death rates, increases people's intention to take the vaccine. Adding a simple qualitative risk level, like 'very low risk', also boosts intentions.
A new MIT model simulates vaccine allocation strategies to predict the effect on cumulative deaths and infections in the US. The research finds that allocating more than 50% of available doses to non-vaccinated individuals can significantly increase lives saved and reduce infections.
A double-blind study found that 12.5% of placebo-treated individuals and 1% of BCG-treated individuals met criteria for confirmed COVID-19, indicating a 92% vaccine effectiveness. The BCG-vaccinated group also displayed protective effects against other infectious diseases, including fewer symptoms and reduced disease events.
Researchers found that two new techniques can help reduce needle fear in primary-aged children, including a distraction game and positive memory reframing. The study involved 41 children and showed promising results for broad vaccination programs.
Researchers assessed the effectiveness of adding a Pfizer-BioNTech booster to two doses of CoronaVac, finding reduced risk of symptomatic SARS-CoV-2 infection. The study used national data from nearly 14 million vaccinated individuals in Malaysia.
A recent study suggests that the BCG vaccine is effective in preventing tuberculosis (TB) in children under 5 years old. However, adolescents and adults may require additional protection to maintain immunity beyond childhood. The researchers emphasize the need for booster vaccinations and new TB vaccines to supplement the BCG vaccine.
A research team at the University of Oklahoma has developed a new approach to triggering an adaptive immune response. The study presents a method to create molecules that can integrate into cells, cause stress on their membrane, and release signals that recruit immune cells to their location.
The new tuberculosis vaccine candidate VPM1002 shows its safety and efficacy in a study of HIV-exposed and non-HIV-exposed newborns. The vaccine has fewer side effects compared to the existing BCG vaccine, and elicits a similar immune response.
A new vaccine formulation has protected newborn mice against respiratory syncytial virus (RSV) and evoked strong responses in human immune cells. The vaccine uses an adjuvant combination that stimulates type 1 T-helper responses, which are hard to stimulate in newborns but are needed for a strong defense against viral pathogens.
The new phage T4-COVID-19 vaccine elicits superior mucosal immunity in mice, inducing robust humoral and cell-mediated immune responses. The vaccine provides complete protection against SARS-CoV-2 variants with minimal lung lesions and no impact on gut microbiota.
A study by UC San Diego researchers reveals health care facilities serving diverse populations were less likely to administer COVID-19 vaccines during the initial rollout. The findings highlight inequities in vaccine distribution, contradicting national policy goals.
Researchers found no significant differences in placental health indicators, birth weights, or Apgar scores between vaccinated and unvaccinated women. Vaccination against COVID-19 was shown to be safe during pregnancy, protecting both mothers and babies from severe illness.
A recent study found that COVID-19 vaccines significantly reduced the risk of infection among NHS hospital workers in England during the second wave. The research showed that without vaccination, staff absence could have been 69% higher and infections peaked in late December 2020.
Researchers developed a mathematical model to predict the efficiency of nanoparticle delivery into cells, particularly in stem cells. They found that nanoparticles become trapped in bubble-like vesicles, preventing them from reaching their targets.
A study published in EMBO Molecular Medicine found that higher levels of memory B cells are associated with a reduced risk of COVID-19 vaccine breakthrough infection. Memory B cells selectively act against specific targets, providing long-lasting immunity and potentially protecting against diverse variants of the virus.
Provincial health ministries hold COVID-19 vaccination data but have been reluctant to share it with researchers. Establishing partnerships between provinces and the Health Data Research Network would enable timely data transfer and support research into vaccine effectiveness.
A new study identifies pox virus proteins that directly interfere with the body's innate immune system, allowing it to evade the host's defense mechanisms. The research team has discovered five 'redox' proteins that interact with Reactive Oxygen Species, which play a key role in destroying pathogens identified by the immune system.
A new study from the University of Georgia suggests that age and risk perception have a significant impact on COVID-19 vaccine acceptance, surpassing political ideology. Older adults (50+) are more likely to consider themselves at risk for severe illness and are universally vaccinated, particularly above 75 years old.
A recent study published in The Lancet Diabetes & Endocrinology found that COVID-19 vaccines significantly reduced severe disease cases across all BMI groups. Vaccine effectiveness was slightly lower in underweight individuals, but substantial reductions in risk were observed for those with healthy weights and higher BMIs.
Researchers have discovered llama-derived immune particles that provide strong protection against a vast array of SARS-like viruses, including COVID-19. These 'super-immunity' molecules, known as nanobodies, could be used to develop a fast-acting, inhalable antiviral treatment or spray.
Scientists locate highly effective memory B cells in the lungs, which can boost the efficacy of vaccines used to protect against viral respiratory diseases. The discovery suggests a promising avenue for increasing vaccine effectiveness.
A clinical trial found that interrupting treatment with methotrexate, a common immune-suppressing drug, doubles the antibody response to COVID-19 booster vaccinations in vulnerable individuals. This improvement is maintained over a 3-month period and has no adverse impact on quality of life.
A new study found that COVID-19 booster shots significantly increase neutralizing antibodies in nursing home residents and their caregivers, offering improved protection against Omicron variants. This research highlights the importance of booster vaccinations for vulnerable populations, including those living at home.
The study investigates relative gaps in COVID-19 vaccination between ethnic groups, finding significant disparities in vaccination rates. Researchers use different population estimate methodologies to analyze the resulting population risk among people in New Zealand.
A study found that over 60% of parents of children with kidney disease or hypertension are unsure or unwilling to vaccinate their child against COVID-19. Effective vaccines exist to protect children from COVID-19, and the findings highlight the need for clear communication to address parental concerns.
Scientists have discovered a new, high-resolution view of the rabies virus glycoprotein, which could lead to more effective vaccines. The study's findings suggest that a better-shaped vaccine could provide lifelong protection against the deadly disease.
A recent study published in the New England Journal of Medicine found that COVID-19 vaccine immunity against new infection appears to wane rapidly, whereas people with a prior-infection were moderately protected from Omicron. Natural immunity provided strong and durable protection against severe illness.